A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma. European Osteosarcoma Intergroup (EOI).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples